Biogen Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 2.2B 2.3B 2.1B 2.1B
Cost of revenue 574.8M 515.6M 536.3M 497.3M
Gross profit 1.6B 1.7B 1.5B 1.6B
Operating expense
Research & development 371.7M 340.0M 370.0M 453.7M
Selling general and admin 506.9M 497.5M 487.9M 579.5M
Other operating expenses 74.3M 63.9M 49.5M 48.7M
Operating income 516.9M 725.9M 532.8M 384.0M
Non operating interest income
Income 26.9M 27.5M 20.4M 15.8M
Expense 57.4M 61.9M 51.1M 51.1M
Other income expense -11.4M -57.5M -236.8M -100.2M
Pretax income 475.0M 634.1M 265.2M 248.4M
Tax provision 77.4M 93.1M 60.3M 21.1M
Net income 397.6M 541.0M 205.0M 227.3M
Basic EPS 4.3 1.7 1.8
Diluted EPS 4.3 1.6 1.8
Basic average shares 124.9M 124.5M 124.2M
Diluted average shares 125.0M 124.9M 124.5M
EBITDA 729.6M 916.3M 708.9M 610.9M
Net income from continuing op. 397.6M 541.0M 205.0M 227.3M
Minority interests 0
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 38 minutes

08:16
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).